Compounds > raloxifene hydrochloride
Page last updated: 2024-08-23

raloxifene hydrochloride and medroxyprogesterone acetate

raloxifene hydrochloride has been researched along with medroxyprogesterone acetate in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (7.41)18.2507
2000's23 (85.19)29.6817
2010's2 (7.41)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dauvois, S; Dumont, M; Hatton, AC; Labrie, C; Labrie, F; Mérand, Y; Poirier, D; Poulin, R; Simard, J; Zhao, HF1
Anderson, PW; Farmer, M; Kuller, LH; Lawrence, JB; Paul, S; Shah, AS; Walsh, BW; Wild, RA1
Fugère, P; Glant, MD; Jolly, E; Scheele, WH; Shah, A; Strack, TR1
Anderson, PW; Cox, DA; Paul, S; Sashegyi, A; Silfen, SL; Walsh, BW1
Kenemans, P; Mijatovic, V; Neele, SJ; Netelenbos, JC; Smolders, RG; van Baal, WM; van der Mooren, MJ; Vogelvang, TE1
Cheng, WC; Hsu, SH; Huang, KE; Pan, HA; Tsai, KS; Wu, MH; Yen, BL; Yen, ML1
Kamp, O; Kenemans, P; Mijatovic, V; Neele, SJ; Netelenbos, JC; Pines, A; van der Mooren, MJ; Vogelvang, TE1
Romero, M1
Amezcua, CA; Boostanfar, R; Felix, JC; Roy, S; Stanczyk, FZ; Tourgeman, DE1
Carranza-Lira, S; Fernandes, CE; Figueroa-Casas, P; Jackson, VP; McNabb, M; Romaguera, J; San Martin, JA; Secrest, RJ1
Fabris, V; Helguero, LA; Lamb, CA; Lanari, C; Lucas, C; Molinolo, AA1
Kourtis, A; Kukuvitis, A; Makedos, G; Panidis, D; Papaiconomou, N; Zournatzi, V1
Christodoulakos, GE; Creatsas, GC; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, CA1
Duschek, EJ; Giltay, EJ; Katan, MB; Neele, SJ; Netelenbos, JC; Zock, PL1
Cerquetani, E; Fini, M; Mercuro, G; Rosano, GM; Vitale, C; Zoncu, S1
Izutsu, T; Sugiyama, T1
Duschek, EJ; Neele, SJ; Netelenbos, C; Rosing, J; Thomassen, MC1
Falbo, A; Lombardi, G; Manguso, F; Mastrantonio, P; Nunziata, V; Orio, F; Palomba, S; Russo, T; Tolino, A; Zullo, F1
Lütjohann, D; Mijatovic, V; Netelenbos, JC; Pinsdorf, U; van der Mooren, MJ; Vogelvang, TE; von Bergmann, K1
Botsis, D; Caramalis, G; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D; Sioulas, V1
Akan, P; Dogan, E; Gol, M; Karas, C; Posaci, C; Saygili, U1
Franke, HR; Vermes, I; Werner, HM1
Christodoulakos, GE; Creatsa, MG; Economou, EV; Kalligerou, I; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Siasou, Z1
Ichikawa, S; Kanda, T; Kasama, S; Kumakura, H; Kurabayashi, M; Murakami, M; Sumino, H; Takahashi, T; Takayama, Y1
Cetin, A; Cetin, M; Durna, A; Erden, O; Guvenal, F; Guvenal, T1
Akercan, F; Akin, M; Akman, L; Duygu, H; Ozerkan, F; Ulukus, M1
He, H; Hu, K; Hu, Q; Li, J; Wang, X; Yang, F; Zeng, C1

Reviews

2 review(s) available for raloxifene hydrochloride and medroxyprogesterone acetate

ArticleYear
Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
    Advance for nurse practitioners, 2002, Volume: 10, Issue:11

    Topics: Chemistry, Pharmaceutical; Climacteric; Drug Combinations; Drug Compounding; Drug Monitoring; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Medroxyprogesterone Acetate; Menopause; Osteoporosis, Postmenopausal; Patient Care Planning; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators

2002
[Hormone therapy for uterine corpus cancer--introduction].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Hydroxyprogesterones; Leuprolide; Medroxyprogesterone Acetate; Raloxifene Hydrochloride; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome

2004

Trials

18 trial(s) available for raloxifene hydrochloride and medroxyprogesterone acetate

ArticleYear
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
    JAMA, 1998, May-13, Volume: 279, Issue:18

    Topics: Aged; Analysis of Variance; Blood Coagulation Factors; Cardiovascular Diseases; Double-Blind Method; Estrogen Antagonists; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Piperidines; Postmenopause; Progesterone Congeners; Prospective Studies; Raloxifene Hydrochloride; Risk Factors

1998
Uterine effects of raloxifene in comparison with continuous-combined hormone replacement therapy in postmenopausal women.
    American journal of obstetrics and gynecology, 2000, Volume: 182, Issue:3

    Topics: Biopsy; Double-Blind Method; Drug Therapy, Combination; Endometrium; Estrogen Antagonists; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Ultrasonography; Uterus

2000
Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women.
    Maturitas, 2001, Jul-25, Volume: 39, Issue:1

    Topics: Aged; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Double-Blind Method; Drug Administration Schedule; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; United States

2001
A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine.
    Maturitas, 2002, Feb-26, Volume: 41, Issue:2

    Topics: Cardiovascular Diseases; Double-Blind Method; Estrogens, Conjugated (USP); Female; Homocysteine; Hormone Replacement Therapy; Humans; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators

2002
Raloxifene versus continuous combined estrogen/progestin therapy: densitometric and biochemical effects in healthy postmenopausal Taiwanese women.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2001, Volume: 12, Issue:12

    Topics: Aged; Bone Density; Double-Blind Method; Drug Combinations; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hip Joint; Humans; Lipids; Lumbar Vertebrae; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uterus

2001
Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: two randomized, placebo-controlled, 2-year studies.
    American journal of obstetrics and gynecology, 2002, Volume: 186, Issue:4

    Topics: Double-Blind Method; Echocardiography; Estrogen Antagonists; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Heart Diseases; Humans; Medroxyprogesterone Acetate; Middle Aged; Placebos; Raloxifene Hydrochloride; Systole; Ventricular Function, Left

2002
Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women.
    American journal of obstetrics and gynecology, 2003, Volume: 188, Issue:2

    Topics: Aged; Breast; Drug Combinations; Estrogens, Conjugated (USP); Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Pain; Postmenopause; Progesterone Congeners; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators

2003
Differential effects of unopposed versus opposed hormone therapy, tibolone, and raloxifene on substance p levels.
    Fertility and sterility, 2003, Volume: 80, Issue:1

    Topics: Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Progesterone Congeners; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Substance P

2003
Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:5

    Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Cholesterol; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Greece; Humans; Lipids; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triglycerides

2004
Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women.
    The Journal of endocrinology, 2004, Volume: 182, Issue:3

    Topics: Aged; Analysis of Variance; Arachidonic Acid; Docosahexaenoic Acids; Double-Blind Method; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Luteinizing Hormone; Male; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Factors; Testosterone; Time Factors

2004
Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:6

    Topics: Aged; Brachial Artery; Cardiovascular Diseases; Cross-Over Studies; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Nitrates; Nitrites; Postmenopause; Pulsatile Flow; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome; Vasodilation

2004
Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:8

    Topics: Activated Protein C Resistance; Aged; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor V; Female; Homocysteine; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Raloxifene Hydrochloride

2004
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2005, Volume: 16, Issue:8

    Topics: Administration, Oral; Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Resorption; Drug Combinations; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Genotype; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Raloxifene Hydrochloride; Receptors, Calcitriol; Selective Estrogen Receptor Modulators; Treatment Outcome

2005
Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women.
    Maturitas, 2005, Apr-11, Volume: 50, Issue:4

    Topics: Alzheimer Disease; Biomarkers; Brain; Cholesterol; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydroxycholesterols; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome

2005
Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Maturitas, 2006, Feb-20, Volume: 53, Issue:3

    Topics: Adult; Aged; C-Reactive Protein; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Norpregnadienes; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome

2006
Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.
    Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:2

    Topics: Adipokines; Adiponectin; Adult; Apoptosis; Atherosclerosis; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fas Ligand Protein; fas Receptor; Female; Greece; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Resistin; Selective Estrogen Receptor Modulators

2008
Effects of different postmenopausal hormone therapy regimens on cerebral blood flow and cognitive functions.
    Advances in therapy, 2009, Volume: 26, Issue:8

    Topics: Adult; Analysis of Variance; Blood Flow Velocity; Cerebrovascular Circulation; Chi-Square Distribution; Cognition; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Mental Status Schedule; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Turkey; Ultrasonography, Doppler, Transcranial

2009
The effects of different hormone treatment on endothelial function in healthy postmenopausal women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:9

    Topics: Adult; Brachial Artery; Drug Combinations; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Health; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Ultrasonography; Vasodilation

2013

Other Studies

7 other study(ies) available for raloxifene hydrochloride and medroxyprogesterone acetate

ArticleYear
Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells.
    Annals of the New York Academy of Sciences, 1990, Volume: 595

    Topics: Androgens; Androstenediol; Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carrier Proteins; Cell Division; Dihydrotestosterone; Estrogens; Gene Expression; Glucocorticoids; Glycoproteins; Humans; In Vitro Techniques; Insulin; Medroxyprogesterone; Medroxyprogesterone Acetate; Membrane Transport Proteins; Neoplasm Proteins; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tumor Cells, Cultured

1990
Growth effects of raloxifene, estradiol, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells.
    Fertility and sterility, 2003, Volume: 79, Issue:1

    Topics: Adenocarcinoma; Cell Division; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tumor Cells, Cultured

2003
Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma.
    Breast cancer research and treatment, 2003, Volume: 79, Issue:1

    Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Chorionic Gonadotropin, beta Subunit, Human; Estradiol; Estrogen Receptor Modulators; Female; Medroxyprogesterone Acetate; Melitten; Mice; Mice, Inbred BALB C; Raloxifene Hydrochloride; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured

2003
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Maturitas, 2005, Apr-11, Volume: 50, Issue:4

    Topics: Adult; Aged; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Testosterone

2005
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
    Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3

    Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured

2005
Effects of raloxifene and hormone replacement therapy on forearm skin elasticity in postmenopausal women.
    Maturitas, 2009, Jan-20, Volume: 62, Issue:1

    Topics: Aged; Bone Density Conservation Agents; Bone Diseases, Metabolic; Case-Control Studies; Elasticity; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Skin

2009
Raloxifene hydrochloride treatment leads to better outcomes than medroxyprogesterone acetate when paired with estrogen in ovariectomized cholesterol-fed rabbits.
    Acta biochimica et biophysica Sinica, 2014, Volume: 46, Issue:12

    Topics: Animals; Cholesterol, Dietary; Estrogen Receptor Modulators; Estrogens; Female; Medroxyprogesterone Acetate; Ovariectomy; Rabbits; Raloxifene Hydrochloride

2014